Mostrar el registro sencillo del ítem
Take control: efficacy and safety of patient-versus physician-managed titration of insulin glargine 300 u/ml (gla-300) in patients with uncontrolled type 2 diabetes
dc.contributor.author | Russell Jones, D. | |
dc.contributor.author | Dauchy, A. | |
dc.contributor.author | Delgado Álvarez, Elías | |
dc.contributor.author | Dimitriadis, G. | |
dc.contributor.author | Frandsen, H. A. | |
dc.contributor.author | Popescu, L. | |
dc.contributor.author | Schultes, B. | |
dc.contributor.author | Strojek, K. | |
dc.contributor.author | Bonnemaire, M. | |
dc.date.accessioned | 2018-06-07T08:57:20Z | |
dc.date.available | 2018-06-07T08:57:20Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | Diabetes Technology & Therapeutics, 20(1), p. A33-A34 (2018); doi:10.1089/dia.2018.2525.abstracts | |
dc.identifier.issn | 1520-9156 | |
dc.identifier.issn | 1557-8593 | |
dc.identifier.uri | http://hdl.handle.net/10651/47377 | |
dc.format.extent | p. A33-A34 | |
dc.language.iso | eng | |
dc.relation.ispartof | Diabetes Technology & Therapeutics, 20(1) | |
dc.rights | © Mary Ann Liebert, Inc | |
dc.source | WOS:000425015800084 | |
dc.title | Take control: efficacy and safety of patient-versus physician-managed titration of insulin glargine 300 u/ml (gla-300) in patients with uncontrolled type 2 diabetes | |
dc.type | conference output | spa |
dc.identifier.doi | 10.1089/dia.2018.2525.abstracts | |
dc.relation.publisherversion | http://dx.doi.org/10.1089/dia.2018.2525.abstracts |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |